These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6262943)

  • 1. Hypothetic mechanism of ticlopidine-induced hypersensitivity to PGE1 in rat platelets.
    Bonne C; Martin B; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):157-64. PubMed ID: 6262943
    [No Abstract]   [Full Text] [Related]  

  • 2. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cyclic nucleotides in platelet function.
    Haslam RJ
    Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
    [No Abstract]   [Full Text] [Related]  

  • 4. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of ticlopidine administration to humans on the binding of adenosine diphosphate to blood platelets.
    Lips NP; Sixma JJ; Schiphorst ME
    Thromb Res; 1980 Jan 1-15; 17(1-2):19-27. PubMed ID: 7376129
    [No Abstract]   [Full Text] [Related]  

  • 6. Initial biochemical responses of platelets to stimulation.
    Mills DC
    Ciba Found Symp; 1975; 35():153-73. PubMed ID: 179766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of platelet aggregation inhibition].
    Abiko Y; Ashida S
    Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonistic effects of N-ethylmaleimide on platelets treated with agents that are known to increase levels of cyclic AMP.
    Wörner P; Patscheke H
    Thromb Res; 1981 Jan 1-15; 21(1-2):201-6. PubMed ID: 6262945
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamic interaction of prostaglandin and norepinephrine in the formation of adenosine 3',5'-monophosphate in human and rabbit platelets.
    Harwood JP; Moskowitz J; Krishna G
    Biochim Biophys Acta; 1971 Feb; 261(2):444-56. PubMed ID: 4335547
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation.
    de Clerck F; Xhonneux B; van de Wiele R
    Agents Actions; 1985 Dec; 17(2):220-8. PubMed ID: 3006459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M; Zahavi J; Kakkar VV
    Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
    Reches A; Eldor A; Salomon Y
    Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.
    Vigdahl RL; Marquis NR; Tavormina PA
    Biochem Biophys Res Commun; 1969 Oct; 37(3):409-15. PubMed ID: 4310667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticlopidine and adenylate cyclase.
    Bonne C; Battais E
    Agents Actions Suppl; 1984; 15():88-96. PubMed ID: 6592947
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenosine-induced cyclic AMP increase in pig lymphocytes is not related to adenylate cyclase stimulation.
    Bonnafous JC; Dornand J; Mani JC
    Biochim Biophys Acta; 1979 Oct; 587(2):180-91. PubMed ID: 226170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma cell adenylate cyclase: direct activation by adenosine and prostaglandins.
    Penit J; Huot J; Jard S
    J Neurochem; 1976 Feb; 26(2):265-73. PubMed ID: 176321
    [No Abstract]   [Full Text] [Related]  

  • 19. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
    Oliva D; Bernini F; Corsini A; Nicosia S
    Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
    Macfarlane DE; Mills DC; Srivastava PC
    Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.